Skip to content
Screener

Itron ITRI Outcomes — R&D

Other segment segments

Networked Solutions
$25.91M-9.9%
Resiliency Solutions
$4.81M+1,250%
Device Solutions
$4.21M-6.6%

Similar metrics at other companies

Insmed logo
INSMARIKAYCE external R&D expenses — R&D
$6.23M-43.4%
Insmed logo
INSMBrensocatib external R&D expenses — R&D
$13.83M-58.8%
Insmed logo
INSMTPIP external R&D expenses — R&D
$38.94M+88.6%
Insmed logo
INSMOther external R&D expenses — R&D
$48.84M+71.7%
Micron Technology logo
MUAEBU — R&D
$109M+0.9%
Micron Technology logo
MUCDBU — R&D
$358M+76.4%

Other financials

Income statement

See full
Revenue$562.9M-7.2%
Gross profit$230.6M+3.1%
Operating income$76.1M-0.5%
Net income$53.3M-22.0%
EPS (diluted)$1.19-19.0%

Balance sheet

See full
Cash & equivalents$745.2M-39.1%
Total debt$1.6B+25.8%
Total equity$1.6B+0.2%
Total assets$4.0B+10.2%

Cash flow

See full
Operating cash flow$88.1M-8.9%
CapEx$6.6M+9.8%
Free cash flow$81.5M-10.1%

Valuation

See full
Market cap$4.5B-21.4%
Enterprise value$5.36B-7.2%
P/E16.4×-4.8×
P/S-0.4×

Profitability

See full
Gross margin39.9%+4.5pp
Operating margin13.2%+1.4pp
Net margin11.9%+0.8pp
FCF margin16.7%+5.0pp

Returns & leverage

See full
Return on equity17%-2.0pp
Debt / equity+0.2×
Current ratio2.7×+0.7×

Where this comes from

Reported directly by Itron in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Itron’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 1:43 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000780571-26-000178
In thousandsDevice SolutionsNetworked SolutionsOutcomesResiliency SolutionsTotal
Total revenues111,445339,23896,39915,820562,902
Adjusted cost of revenues (1)72,686194,08459,0193,903
Adjusted sales, general and administrative3,0267,1854,5672,728
Adjusted research and development4,21225,90812,2714,813
Adjusted segment operating income31,521112,06120,5424,376168,500
Reconciliation of adjusted segment operating income
Amortization of core-developed technology intangible assets(2,570)
Corporate unallocated expenses(89,864)

Item 1: Financial Statements (Unaudited)

FAQ

What is Itron's outcomes — R&D?
Itron (ITRI) reported outcomes — R&D of $12.27M in Q2 2026.
How has Itron's outcomes — R&D changed year-over-year?
Itron's outcomes — R&D decreased by 1.5% year-over-year, from $12.46M to $12.27M.
What is the long-term trend for Itron's outcomes — R&D?
Over 3 years (2022 to 2025), Itron's outcomes — R&D has grown at a 7.5% compound annual growth rate (CAGR), from $39.42M to $48.99M.
What does outcomes — R&D mean?
Reflects the investment in innovation, software development, and product enhancement specifically for the Outcomes segment. High investment levels indicate a focus on maintaining a competitive edge in digital energy and water management solutions.

Ask your AI about Itron's outcomes — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude